+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Breast Biopsy Market by Product, Type, Guidance, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6011422
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Breast Biopsy Market grew from USD 1.00 billion in 2023 to USD 1.09 billion in 2024. It is expected to continue growing at a CAGR of 9.26%, reaching USD 1.87 billion by 2030.

The breast biopsy market encompasses a range of medical procedures designed to diagnose abnormalities in breast tissue, primarily to detect breast cancer. It involves taking a sample of breast tissue to be examined under a microscope to discern the presence of disease. The necessity of breast biopsy stems from its crucial role in early cancer detection, which significantly enhances treatment success rates and patient outcomes. Applications of breast biopsy extend across hospitals, diagnostic centers, and specialty clinics, covering techniques such as fine needle aspiration, core needle biopsy, and surgical biopsy. End-users mainly include healthcare providers and practitioners seeking detailed tissue analyses for accurate diagnostics. Market growth is influenced by factors such as the rising prevalence of breast cancer, increasing awareness efforts promoting early detection, and technological advancements in imaging and biopsy tools. Furthermore, government initiatives and funding aimed at breast cancer research bolster market expansion. Opportunities abound in the development of less-invasive techniques and the integration of AI and improved imaging systems for precision diagnostics, suggesting that investing in R&D could yield significant returns. Innovators should also focus on enhancing patient comfort and reducing procedural complications to augment adoption rates. However, market growth faces limitations such as the high cost of equipment and biopsy procedures, along with concerns over procedure-related complications and psychological impacts on patients. Accessibility issues in developing regions further hinder market potential. Nonetheless, areas ripe for innovation include non-invasive liquid biopsies and molecular diagnostics, which could transform patient pathways and ease procedural burdens. The breast biopsy market is dynamic, reflecting a trajectory toward more patient-friendly, accurate, and cost-effective solutions. Companies should leverage insights into consumer preferences and technological advancements to set themselves apart in this evolving landscape, ensuring alignment with broader healthcare trends and demands.

Understanding Market Dynamics in the Breast Biopsy Market

The Breast Biopsy Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising prevalence of breast cancer worldwide
    • Government initiative for awareness and treatment of breast cancer
    • Shifting preferences for early detection and screening for breast cancer
  • Market Restraints
    • High-cost and time consuming procedure
  • Market Opportunities
    • Emergence of liquid biopsy and promising clinical trials
    • Increasing investments and funding for R&D of breast cancer treatment
  • Market Challenges
    • Possibilities of infection associated with biopsy needles

Exploring Porter’s Five Forces for the Breast Biopsy Market

Porter’s Five Forces framework further strengthens the insights of the Breast Biopsy Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Breast Biopsy Market

External macro-environmental factors deeply influence the performance of the Breast Biopsy Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Breast Biopsy Market

The Breast Biopsy Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Breast Biopsy Market

The Breast Biopsy Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Breast Biopsy Market

The Breast Biopsy Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Breast Biopsy Market, highlighting leading vendors and their innovative profiles. These include Argon Medical, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc, Biocept, Inc., Cook Group Incorporated, CooperSurgical, Inc., F. Hoffmann-La Roche Ltd., Fluxion Biosciences Inc., FUJIFILM Corporation, GE HealthCare, Guardant Health, Halma plc, Hologic, Inc., Illumina, Inc., INRAD, Inc., Iskus Health Ltd., Johnson & Johnson Services, Inc., Leica Biosystems Nussloch GmbH, Medtronic PLC, Merit Medical Systems, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific Inc., TransMed7, LLC, and Trivitron Healthcare.

Market Segmentation & Coverage

This research report categorizes the Breast Biopsy Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Assay Kits
    • Biopsy Needles
    • Biopsy Tables
    • Guidance Systems
    • Liquid Biopsy Instruments
    • Localization Wires
  • Type
    • Liquid Breast Biopsy
      • Circulating Tumor Cells
      • Circulating Tumor DNA
    • Needle Breast Biopsy
      • Core Needle Biopsy
      • Fine Needle Aspiration Biopsy
      • Vacuum-Assisted Biopsy
    • Open Surgical Breast Biopsy
      • Excisional
      • Incisional
  • Guidance
    • Image-Guided Biopsy
      • Mammography-Guided Stereotactic Biopsy
      • MRI Guided Biopsy
      • Ultrasound-Guided Biopsy
    • Liquid Biopsy
      • Microarray-Based Biopsy
      • NGS-Based Biopsy
      • PCR-Based Biopsy
  • Application
    • Early Cancer Screening
    • Recurrence Monitoring
    • Therapy Selection
    • Treatment Monitoring
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of breast cancer worldwide
5.1.1.2. Government initiative for awareness and treatment of breast cancer
5.1.1.3. Shifting preferences for early detection and screening for breast cancer
5.1.2. Restraints
5.1.2.1. High-cost and time consuming procedure
5.1.3. Opportunities
5.1.3.1. Emergence of liquid biopsy and promising clinical trials
5.1.3.2. Increasing investments and funding for R&D of breast cancer treatment
5.1.4. Challenges
5.1.4.1. Possibilities of infection associated with biopsy needles
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Breast Biopsy Market, by Product
6.1. Introduction
6.2. Assay Kits
6.3. Biopsy Needles
6.4. Biopsy Tables
6.5. Guidance Systems
6.6. Liquid Biopsy Instruments
6.7. Localization Wires
7. Breast Biopsy Market, by Type
7.1. Introduction
7.2. Liquid Breast Biopsy
7.2.1. Circulating Tumor Cells
7.2.2. Circulating Tumor DNA
7.3. Needle Breast Biopsy
7.3.1. Core Needle Biopsy
7.3.2. Fine Needle Aspiration Biopsy
7.3.3. Vacuum-Assisted Biopsy
7.4. Open Surgical Breast Biopsy
7.4.1. Excisional
7.4.2. Incisional
8. Breast Biopsy Market, by Guidance
8.1. Introduction
8.2. Image-Guided Biopsy
8.2.1. Mammography-Guided Stereotactic Biopsy
8.2.2. MRI Guided Biopsy
8.2.3. Ultrasound-Guided Biopsy
8.3. Liquid Biopsy
8.3.1. Microarray-Based Biopsy
8.3.2. NGS-Based Biopsy
8.3.3. PCR-Based Biopsy
9. Breast Biopsy Market, by Application
9.1. Introduction
9.2. Early Cancer Screening
9.3. Recurrence Monitoring
9.4. Therapy Selection
9.5. Treatment Monitoring
10. Americas Breast Biopsy Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Breast Biopsy Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Breast Biopsy Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Quest Diagnostics to Acquire Haystack Oncology, Adding Sensitive Liquid Biopsy Technology for Improving Personalized Cancer Care to Oncology Portfolio
13.3.2. Guardant Health Receives FDA Approval for Guardant360 CDx as Companion Diagnostic for Menarini Group’s ORSERDU for the Treatment of Patients with ESR1 Mutations in ER+, HER2- Advanced or Metastatic Breast Cancer
13.3.3. TransMed7, LLC Announces First Clinical Use of SpeedBird Breast Biopsy Devices for Commercial Launch
13.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. BREAST BIOPSY MARKET RESEARCH PROCESS
FIGURE 2. BREAST BIOPSY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BREAST BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BREAST BIOPSY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL BREAST BIOPSY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL BREAST BIOPSY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES BREAST BIOPSY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES BREAST BIOPSY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. BREAST BIOPSY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. BREAST BIOPSY MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. BREAST BIOPSY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BREAST BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BREAST BIOPSY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. BREAST BIOPSY MARKET DYNAMICS
TABLE 7. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BREAST BIOPSY MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY NEEDLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY TABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BREAST BIOPSY MARKET SIZE, BY GUIDANCE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BREAST BIOPSY MARKET SIZE, BY LOCALIZATION WIRES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BREAST BIOPSY MARKET SIZE, BY CIRCULATING TUMOR CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BREAST BIOPSY MARKET SIZE, BY CIRCULATING TUMOR DNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BREAST BIOPSY MARKET SIZE, BY EXCISIONAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BREAST BIOPSY MARKET SIZE, BY INCISIONAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BREAST BIOPSY MARKET SIZE, BY MAMMOGRAPHY-GUIDED STEREOTACTIC BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI GUIDED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BREAST BIOPSY MARKET SIZE, BY MICROARRAY-BASED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BREAST BIOPSY MARKET SIZE, BY NGS-BASED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BREAST BIOPSY MARKET SIZE, BY PCR-BASED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BREAST BIOPSY MARKET SIZE, BY EARLY CANCER SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BREAST BIOPSY MARKET SIZE, BY RECURRENCE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BREAST BIOPSY MARKET SIZE, BY THERAPY SELECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BREAST BIOPSY MARKET SIZE, BY TREATMENT MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. CANADA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. CANADA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. CANADA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 75. CANADA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 76. CANADA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 77. CANADA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 78. CANADA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 79. CANADA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 80. CANADA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. MEXICO BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. MEXICO BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. MEXICO BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 84. MEXICO BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 85. MEXICO BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 86. MEXICO BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 87. MEXICO BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 88. MEXICO BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 89. MEXICO BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES BREAST BIOPSY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 100. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 110. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 113. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 114. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. CHINA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. CHINA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. CHINA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 122. CHINA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 123. CHINA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 124. CHINA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 125. CHINA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 126. CHINA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 127. CHINA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. INDIA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. INDIA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. INDIA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 131. INDIA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 132. INDIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 133. INDIA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 134. INDIA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 135. INDIA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 136. INDIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. INDONESIA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. INDONESIA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. INDONESIA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 140. INDONESIA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 141. INDONESIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 142. INDONESIA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 143. INDONESIA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 144. INDONESIA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 145. INDONESIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. JAPAN BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. JAPAN BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. JAPAN BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 149. JAPAN BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 150. JAPAN BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 151. JAPAN BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 152. JAPAN BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 153. JAPAN BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 154. JAPAN BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. MALAYSIA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. MALAYSIA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 157. MALAYSIA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 158. MALAYSIA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 159. MALAYSIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 160. MALAYSIA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 161. MALAYSIA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 162. MALAYSIA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 163. MALAYSIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 166. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 167. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 168. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 169. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 170. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 171. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 172. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. SINGAPORE BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. SINGAPORE BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 175. SINGAPORE BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 176. SINGAPORE BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 177. SINGAPORE BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 178. SINGAPORE BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 179. SINGAPORE BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 180. SINGAPORE BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 181. SINGAPORE BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 184. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 185. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 186. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 187. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 188. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 189. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 190. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. TAIWAN BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 192. TAIWAN BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 193. TAIWAN BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 194. TAIWAN BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 195. TAIWAN BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 196. TAIWAN BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 197. TAIWAN BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 198. TAIWAN BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 199. TAIWAN BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. THAILAND BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 201. THAILAND BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 202. THAILAND BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 203. THAILAND BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 204. THAILAND BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 205. THAILAND BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 206. THAILAND BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 207. THAILAND BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 208. THAILAND BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. VIETNAM BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. VIETNAM BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 211. VIETNAM BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 212. VIETNAM BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 213. VIETNAM BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 214. VIETNAM BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 215. VIETNAM BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 216. VIETNAM BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 217. VIETNAM BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 228. DENMARK BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. DENMARK BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 230. DENMARK BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 231. DENMARK BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 232. DENMARK BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 233. DENMARK BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 234. DENMARK BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 235. DENMARK BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 236. DENMARK BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. EGYPT BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 238. EGYPT BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 239. EGYPT BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 240. EGYPT BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 241. EGYPT BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 242. EGYPT BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 243. EGYPT BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 244. EGYPT BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 245. EGYPT BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. FINLAND BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 247. FINLAND BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 248. FINLAND BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 249. FINLAND BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 250. FINLAND BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 251. FINLAND BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 252. FINLAND BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 253. FINLAND BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 254. FINLAND BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. FRANCE BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 256. FRANCE BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 257. FRANCE BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 258. FRANCE BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 259. FRANCE BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 260. FRANCE BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 261. FRANCE BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 262. FRANCE BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 263. FRANCE BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. GERMANY BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 265. GERMANY BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 266. GERMANY BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 267. GERMANY BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 268. GERMANY BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 269. GERMANY BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 270. GERMANY BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 271. GERMANY BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 272. GERMANY BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. ISRAEL BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 274. ISRAEL BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 275. ISRAEL BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 276. ISRAEL BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 277. ISRAEL BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 278. ISRAEL BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 279. ISRAEL BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 280. ISRAEL BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 281. ISRAEL BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 282. ITALY BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 283. ITALY BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 284. ITALY BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 285. ITALY BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 286. ITALY BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 287. ITALY BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 288. ITALY BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 289. ITALY BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 290. ITALY BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 291. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 292. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 293. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 294. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 295. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 296. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 297. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 298. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 299. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 300. NIGERIA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 301. NIGERIA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 302. NIGERIA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 303. NIGERIA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 304. NIGERIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 305. NIGERIA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 306. NIGERIA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 307. NIGERIA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 308. NIGERIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 309. NORWAY BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 310. NORWAY BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 311. NORWAY BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 312. NORWAY BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 313. NORWAY BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 314. NORWAY BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 315. NORWAY BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 316. NORWAY BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 317. NORWAY BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 318. POLAND BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 319. POLAND BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 320. POLAND BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 321. POLAND BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 322. POLAND BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 323. POLAND BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 324. POLAND BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 325. POLAND BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 326. POLAND BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 327. QATAR BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 328. QATAR BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 329. QATAR BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 330. QATAR BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 331. QATAR BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 332. QATAR BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 333. QATAR BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 334. QATAR BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 335. QATAR BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 336. RUSSIA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 337. RUSSIA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 338. RUSSIA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 339. RUSSIA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 340. RUSSIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 341. RUSSIA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 342. RUSSIA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 343. RUSSIA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 344. RUSSIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 345. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 346. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 347. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 348. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 349. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 350. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 351. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 352. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 353. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 354. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 355. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 356. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 357. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 358. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
TABLE 359. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
TABLE 360. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 361. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY LIQUID

Companies Mentioned

The leading players in the Breast Biopsy market, which are profiled in this report, include:
  • Argon Medical
  • Becton, Dickinson, and Company
  • Bio-Rad Laboratories, Inc
  • Biocept, Inc.
  • Cook Group Incorporated
  • CooperSurgical, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Fluxion Biosciences Inc.
  • FUJIFILM Corporation
  • GE HealthCare
  • Guardant Health
  • Halma plc
  • Hologic, Inc.
  • Illumina, Inc.
  • INRAD, Inc.
  • Iskus Health Ltd.
  • Johnson & Johnson Services, Inc.
  • Leica Biosystems Nussloch GmbH
  • Medtronic PLC
  • Merit Medical Systems
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • TransMed7, LLC
  • Trivitron Healthcare

Methodology

Loading
LOADING...

Table Information